Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Clínica de asma y alergia Dres. Ojeda

Verified siteinfo

Spain C/ Oquendo 23, 28006 Madrid, Spain

  • 1 trial recruiting
  • Conjunctivitis allergic · Asthma · Rhinitis allergic
  • Adults and children

About Specializations

Clínica de asma y alergia Dres. Ojeda in Madrid, Spain specialises in clinical trials of conditions such as Conjunctivitis allergic, Asthma, Rhinitis allergic, Seasonal allergy, and other specialisations. This site conducts important research.

Main research areas of the site

Allergy and Immunology

The medical center is at the forefront of allergy and immunology research, focusing on innovative approaches to diagnose and treat allergic conditions. The center's research is particularly concentrated on the development and assessment of allergen extracts and vaccines.

  • Phleum pratense and Dactylis glomerata allergen extracts
  • Vaccine efficacy for grass and cupressaceae allergies

Through rigorous clinical trials, the center aims to enhance the understanding of allergen-induced reactions and improve therapeutic strategies for individuals suffering from allergic rhinitis and rhinoconjunctivitis, with or without associated asthma.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
C/ Oquendo 2328006 MadridSpain
Open in maps ↗
Recruiting now
1 trial
Conditions studied
6
Partner status
Verified site

More sites in MadridSpain

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

5 clinical trials

Conjunctivitis allergic+3

Recruiting

Study on the Effectiveness and Safety of a Grass and Juniperus Oxycedrus Allergy Vaccine for Patients with Allergic Rhinitis or Rhinoconjunctivitis with or without Mild Asthma

Investigational
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years
  • Substances:Allergen Extract From Dactylis Glomerata Pollen, Glutaraldehyde-Modified
  • Sponsor:Inmunotek S.L.

Conjunctivitis allergic

Not recruiting

Study of bilastine for effectiveness, safety and quality of life in children aged 6 to 12 years with allergic rhinoconjunctivitis

Registered drugNo placebo
Countries:SpainSpain
  • Participants:0–17 years
  • Substances:Bilastine
  • Sponsor:A. Menarini Industrie Farmaceutiche Riunite S.r.l.

Chronic spontaneous urticaria

Not recruiting

Study on the Effects of EVO756 in Adults with Moderate to Severe Chronic Spontaneous Urticaria

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:EVO756 potassium
  • Sponsor:Evommune Inc.

Conjunctivitis allergic+3

Not recruiting

Study on the Effectiveness and Safety of a Grass and Olive Pollen Allergy Vaccine for Patients with Allergic Rhinitis or Asthma

Investigational
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years
  • Substances:Allergen Extract From Dactylis Glomerata Pollen, Glutaraldehyde-Modified
  • Sponsor:Inmunotek S.L.

Allergy test

Not recruiting

Study on Allergy to Phleum pratense and Dactylis glomerata: Testing Reactions to Phleum pratense and Dactylis glomerata Pollen Extracts in Patients with Allergies

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Sodium Chloride
  • Sponsor:Inmunotek S.L.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.